Time Course of Juvenile Onset Recurrent Respiratory Papillomatosis Caused by Human Papillomavirus

Pediatric Infectious Disease Journal

Volumn 27, Issue 2, 2008, Pages 149-154

  Hawkes, Michael ^a   Campisi, Paolo ^a   Zafar, Rubeena ^a   Punthakee, Xerxes ^a   Dupuis, Annie ^a   Forte, Vito ^a   Ford Jones, Elizabeth Lee ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Human papillomavirus; Mathematical modeling; Recurrent respiratory papillomatosis

Indexed keywords

3 INDOLEMETHANOL; CIDOFOVIR; INTERFERON;

ADOLESCENT; ARTICLE; CANADA; CHILD; CYTOREDUCTIVE SURGERY; DISEASE COURSE; FEMALE; HOARSENESS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PAPILLOMATOSIS; PRIORITY JOURNAL; RECURRENT RESPIRATORY PAPILLOMATOSIS; WART VIRUS; ALPHAPAPILLOMAVIRUS; INFANT; PATHOLOGY; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; TIME; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ALPHAPAPILLOMAVIRUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PAPILLOMAVIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 40949153127     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318159833e     Document Type: Article

References (17)

1. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicen- tre phase II efficacy trial. Lancet Oncol. 2005;6:271-278.
2. Zawisza J. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. Washington, DC: Food and Drug Administration; 2006.
3. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope. 2004;114:1-23.
4. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2003;129:976-982.
5. Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg. 1999;125:743-748.
6. Silver RD, Rimell FL, Adams GL, Derkay CS, Hester R. Diagnosis and management of pulmonary metastasis from recurrent respiratory papil-lomatosis. Otolaryngol Head Neck Surg. 2003;129:622-629.
7. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg. 2004;130:711-716.
8. Motulsky H. Christopoulos A. Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting. Oxford, England: Oxford University Press; 2004.
9. Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope. 1997;107:915-918.
10. Derkay CS, Smith RJ, McClay J, et al. HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol. 2005;114:730-737.
11. Soldatski IL, Onufrieva EK, Steklov AM, Schepin NV. Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope. 2005; 115:1848-1854.
12. Chadha NK, James AL. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev. 2005;19:CD005053.
13. Kashima H, Leventhal B, Clark K, et al. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions. Laryngoscope. 1988; 98:334-340.
14. Leventhal BG, Kashima HK, Weck PW, et al. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg. 1988;114:1163-1169.
15. Healy GB, Gelber RD, Trowbridge AL, Grundfast KM, Ruben RJ, Price KN. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl J Med. 1988;319:401-407.
16. Leventhal BG, Kashima HK, Mounts P, et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N Engl J Med. 1991;325: 613-617.
17. Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004;68:1493-1498.